The androgen receptor (AR) is important in the development of both experimental and human bladder cancer, yet the role of AR in bladder cancer growth and progression is less clear, with the literature indicating that more advanced stage and grade disease are associated with reduced AR expression [75,76]. This evidence concerns the gene AR and urinary bladder carcinoma.